Surgical instrument

Product Design Development Services Market to Record a Growth of USD 5.74 billion between 2022 and 2027, Asia to Occupy 46% Market Share - Technavio

Retrieved on: 
Wednesday, January 31, 2024
Growth, Research, USD, Safety, Sample, Surgical instrument, Application, Instrument, Heart rate, Risk, Exclusive, Geography, Medical device

NEW YORK, Jan. 30, 2024 /PRNewswire/ -- The product design development services market is set to grow by USD 5.74 billion from 2022 to 2027 progressing at a CAGR of 9.44% during the forecast period.

Key Points: 
  • NEW YORK, Jan. 30, 2024 /PRNewswire/ -- The product design development services market is set to grow by USD 5.74 billion from 2022 to 2027 progressing at a CAGR of 9.44% during the forecast period.
  • The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment.
  • Countries including China and India has significant growth in various industries such as manufacturing, healthcare, and technology.
  • The APAC product design and development services market is driven by growing demand for innovative, high-quality products and the need to reduce costs and improve efficiency.

Indonesia's ITS Launches 7 MedTech Devices Based on Various Integrated Technologies

Retrieved on: 
Thursday, November 9, 2023
VR, ITS, Digital, Health, University, Medtech, Research, Hospital, RSUA, Jakarta Convention Center, 3D, Artificial intelligence, Digital 3D, Surgical instrument, Digital technology, Augmented reality, Patient, Virtual reality, Finger

Sepuluh Nopember Institute of Technology (ITS) has developed 7 medical devices based on integrated technologies, contributing significantly to Indonesia's nascent MedTech industry [Image: ITS].

Key Points: 
  • Sepuluh Nopember Institute of Technology (ITS) has developed 7 medical devices based on integrated technologies, contributing significantly to Indonesia's nascent MedTech industry [Image: ITS].
  • The seven devices use integrated 3D design and digital fabrication technology.
  • Through fabrication technology, products can be customized and made based on consumer request.
  • Bambang Pramujati, ITS Deputy Rector, said: The launch of these medtech devices is proof of ITS' commitment to developing technology in the health sector.

Global Medical Devices Market Report 2023: Sector is Expected to Reach $695.2 Billion by 2031 at a CAGR of 6.2% - ResearchAndMarkets.com

Retrieved on: 
Wednesday, May 24, 2023
Medical Devices, Health, Infection, Birth, Medicine, Insulin, Pregnancy, Diabetes, USB On-The-Go, Cardiovascular disease, Ageing, Cancer, Quality of life, Surgical instrument, ECG, Intrauterine device, USD, Hospital, Chronic condition, Patient, Vels Institute of Science, Technology & Advanced Studies, Prevalence, Diagnosis, Condom, FDA, Disease, Medical device

The "Global Medical Devices Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Medical Devices Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering.
  • The global medical devices market attained a value of about USD 562.6 billion in 2022.
  • Medical devices have a wide range of applications and can be used in various healthcare settings, including hospitals, clinics, and home care.
  • The medical devices market is driven by the following factors:
    Technological Advancements: Technological advancements in medical devices, such as the development of minimally invasive procedures, advanced materials, and 3D printing, are driving market growth.

Sight Sciences Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial Results

Retrieved on: 
Monday, January 9, 2023
Surgical instrument, Glaucoma, Duane syndrome, CFO, St. Jude Medical, Partnership, Growth, Abbott Laboratories, Market for corporate control, Video game, Fossil fuel, Management, Finance

The Company is announcing preliminary unaudited financial results for the fourth quarter and year ended December 31, 2022.

Key Points: 
  • The Company is announcing preliminary unaudited financial results for the fourth quarter and year ended December 31, 2022.
  • “We are pleased with the strong performance across our entire business in 2022,” said Paul Badawi, Founder and Chief Executive Officer of Sight Sciences.
  • The Company expects to announce complete fourth quarter and full year 2022 financial results in March 2023.
  • The select preliminary, unaudited results described in this press release are estimates only and are subject to revision until the Company reports its full financial and business results for the quarter and year ended December 31, 2022.

Verana Health and Sight Sciences Collaborate on Glaucoma Research Using Curated Real-World Data from the IRIS Registry

Retrieved on: 
Wednesday, January 4, 2023
Exocrine gland, SAN, HCP, Optic nerve, Surgical instrument, Duane syndrome, Safety, Diabetic retinopathy, Health, Research, American Academy, Intraocular pressure, Patient, Trabecular meshwork, American Academy of Ophthalmology, American Academy of Neurology, PARK, IOP, Machine Intelligence Research Institute, Glaucoma, FDA, State, Geographic atrophy, Trauma, MD, Data management, American Urological Association, Severe cognitive impairment, Database, Doctor of Philosophy, RWD, MIGS, Quality of life, Surgeon, Catheter, HCPS, Laika (EHR testing framework), Medicine, Eye, IRIS, OMNI, MGD, Physician, Cataract, Pharmaceutical industry, Dentistry, Medical imaging, Medical device, Ophthalmology

SAN FRANCISCO and MENLO PARK Calif., Jan. 4, 2023 /PRNewswire/ -- Verana Health®—a digital health company elevating quality in real-world data (RWD)—and Sight Sciences, Inc. (NASDAQ: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients' lives, today announced a research collaboration designed to provide insights that may lead to improved outcomes for patients with primary open-angle glaucoma (POAG).

Key Points: 
  • Powered by real-world glaucoma data curated from the American Academy of Ophthalmology (Academy) IRIS® Registry (Intelligent Research in Sight), Qdata Glaucoma is the only data module that captures the full, real-world glaucoma patient journey.
  • This fit-for-purpose data module offers curated data for:
    The IRIS Registry is one of the largest specialty society clinical data registries in all of medicine and the first comprehensive eye disease clinical registry in the U.S.
  • Michael Mbagwu, MD, senior medical director for Verana Health says, "Sight Sciences shares our goal of improving outcomes and treatments for people with glaucoma.
  • Using its clinician-informed and artificial intelligence-enhanced VeraQ® population health data engine, Verana Health transforms structured and unstructured healthcare data into curated, disease-specific data modules, Qdata®.

Sight Sciences to Present at the Upcoming Piper Sandler 34th Annual Healthcare Conference

Retrieved on: 
Tuesday, November 22, 2022
Intraocular pressure, Eye, Conference, MIGS, Health, Physician, Patient, MGD, Surgical instrument, Exocrine gland, Interest, Duane syndrome, Severe cognitive impairment, Trabecular meshwork, Medical imaging

MENLO PARK, Calif., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients lives, today announced plans to participate in the upcoming Piper Sandler 34th Annual Healthcare Conference in New York, NY.

Key Points: 
  • MENLO PARK, Calif., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients lives, today announced plans to participate in the upcoming Piper Sandler 34th Annual Healthcare Conference in New York, NY.
  • Sight Sciences management is scheduled to participate in a fireside chat on Wednesday, November 30, 2022, at 11:30am ET.
  • Interested parties may access a live and archived webcast of the fireside chat on the Investors section of the companys website at: https://investors.sightsciences.com/ .
  • Sight Sciences is an eyecare technology company focused on developing and commercializing innovative solutions intended to transform care and improve patients lives.

Sight Sciences Reports Third Quarter 2022 Financial Results

Retrieved on: 
Thursday, November 10, 2022
Investor, GLOBE, Private Securities Litigation Reform Act, Forward-looking statement, Intellectual property, Adult, Glaucoma, Eye, Duane syndrome, Exocrine gland, OMNI, Jumpstart Our Business Startups Act, Nasdaq, Webcast, Baozou Big News Events, Health, Adoption, IOP, SG, Surgical instrument, COVID-19, Ophthalmology, Securities Act of 1933, Trabecular meshwork, MIGS, Severe cognitive impairment, U.S. Securities and Exchange Commission, Securities Exchange Act of 1934, Time, Company, MGD, Clinical trial, Patient, Physician, Intraocular pressure, Growth, Ciclosporin, News, Industry, History, Regulation, Renewable energy, Video game, Medical imaging, Pharmaceutical industry

MENLO PARK, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients lives, today reported financial results for the third quarter ended September 30, 2022.

Key Points: 
  • MENLO PARK, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients lives, today reported financial results for the third quarter ended September 30, 2022.
  • Revenue for the third quarter of 2022 was $18.7 million, an increase of $5.6 million, or 43%, compared to the third quarter of 2021.
  • Gross profit for the third quarter of 2022 was $15.7 million compared to $11.0 million for the third quarter of 2021.
  • Operating expenses as a percentage of revenues increased from 191.4% in the third quarter of 2021 to 201.3% in the third quarter of 2022.

Aspen Surgical Acquires Symmetry Surgical

Retrieved on: 
Thursday, October 27, 2022
Medical Devices, Health, Hospitals, Surgery, Health Technology, General Health, Growth, Solution, FLASH, Kirkland & Ellis, Patient, ACCESS, CEO, Multimedia, Surgical instrument, AND, Acquisition, ULTRA, MIDAS, Private equity, History, Golub Capital, Efficiency, Life, LinkedIn, Consumer, Safety, Financial services, Medical device, Audax, Aspen, Symmetry

Aspen Surgical Products, Inc. (Aspen), a portfolio company of Audax Private Equity (Audax) and a leader in disposable surgical products, announced the acquisition of Symmetry Surgical (Symmetry) from RoundTable Healthcare Partners.

Key Points: 
  • Aspen Surgical Products, Inc. (Aspen), a portfolio company of Audax Private Equity (Audax) and a leader in disposable surgical products, announced the acquisition of Symmetry Surgical (Symmetry) from RoundTable Healthcare Partners.
  • There is great power in bringing the people, products, and brands of Aspen and Symmetry together, added Brian Straeb, CEO of Symmetry.
  • Symmetry Surgical is a leading healthcare technology and solutions supplier of high-quality surgical instrumentation, a full-line electrosurgery portfolio, and minimally invasive surgical devices that support all surgical specialties and sites of care.
  • Wherever surgeries are performed, surgical teams can trust that Symmetry Surgical instruments and devices will operate efficiently and safely.

Sight Sciences to Report Third Quarter 2022 Financial Results on November 10, 2022

Retrieved on: 
Thursday, October 20, 2022
Physician, Surgical instrument, Webcast, Exocrine gland, Investor, Patient, Trabecular meshwork, Eye, Severe cognitive impairment, Intraocular pressure, Nasdaq, MGD, Health, Adult, Duane syndrome, GLOBE, News, MIGS, Medical imaging

MENLO PARK, Calif., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc .

Key Points: 
  • MENLO PARK, Calif., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc .
  • (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients lives, today announced it will report financial results for the third quarter ended September 30, 2022, after the market close on Thursday, November 10, 2022.
  • The companys management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
  • Sight Sciences is an eyecare technology company focused on developing and commercializing innovative solutions intended to transform care and improve patients lives.

Medical Ceramics Market is expected to grow by US$ 4.89 Billion during 2022-2030, Accelerating at a CAGR of 6.4%, Growth Plus Reports

Retrieved on: 
Thursday, October 6, 2022
Traction, Stainless steel, Plastic surgery, Surgical instrument, Corrosion, CVD, CAGR, Impact, Fracture, US, Incidence, Conditional sentence, Degenerative disease, Hip, COVID-19, Ceramic, Dental, Medical device

NEW YORK, Oct. 6, 2022 /PRNewswire/ -- According to a new market research report titled, " Medical Ceramics Market by Material (Bioinert Ceramics, Bioactive Ceramics, Bioresorbable Ceramics, Piezoceramics), by Application (Dental, Orthopedic, Cardiovascular, Surgical Instrument, Diagnostic Instrument, Plastic Surgery, Others) Global Outlook & Forecast 2022-2030" published by growth plus reports, the medical ceramics market is expected to grow at a CAGR of 6.4% from 2021 to reach US$ 4.89 billion by 2030.

Key Points: 
  • NEW YORK, Oct. 6, 2022 /PRNewswire/ -- According to a new market research report titled, " Medical Ceramics Market by Material (Bioinert Ceramics, Bioactive Ceramics, Bioresorbable Ceramics, Piezoceramics), by Application (Dental, Orthopedic, Cardiovascular, Surgical Instrument, Diagnostic Instrument, Plastic Surgery, Others) Global Outlook & Forecast 2022-2030" published by growth plus reports, the medical ceramics market is expected to grow at a CAGR of 6.4% from 2021 to reach US$ 4.89 billion by 2030.
  • The primary driver of the global medical ceramics market is the increased demand for medical implants resulting from rising incidence of chronic diseases including cardiovascular diseases (CVDs), spinal cord disorders, etc.
  • Based on material types, the global medical ceramics market is divided into:
    The bioinert ceramics segment dominates the global medical ceramics market with the largest market share in 2021.
  • Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://growthplusreports.com/inquiry/speak-analyst/medical-ceramics-mar...
    Based on application, the global medical ceramics market iscategorizedinto: